Effect of surface coating on the biocompatibility and in vivo MRI detection of iron oxide nanoparticles after intrapulmonary administration

References

• Ai J, Biazar E, Jafarpour M, Montazeri M, Majdi A, Aminifard S, et al. 2011. Nanotoxicology and nanoparticle safety in biomedical designs. Int J Nanomedicine 6:1117–27
   PubMedGoogle Scholar
• Al Faraj A, Gazeau F, Wilhelm C, Devue C, Guerin CL, Pechoux C, et al. 2012. Endothelial cell-derived microparticles loaded with iron oxide nanoparticles: feasibility of MR imaging monitoring in mice. Radiology 263:169–78
   PubMed Web of Science ®Google Scholar
• Al Faraj A, Shaik AS, Afzal S, Al Sayed B, Halwani R. 2014a. MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles. Int J Nanomed 9:1491–503
   PubMed Web of Science ®Google Scholar
• Al Faraj A, Sultana Shaik A, Pureza MA, Alnafea M, Halwani R. 2014b. Preferential macrophage recruitment and polarization in LPS-induced animal model for COPD: noninvasive tracking using MRI. PLoS One 9:e90829
   PubMed Web of Science ®Google Scholar
• Azarmi S, Roa WH, Lobenberg R. 2008. Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Deliv Rev 60:863–75
   PubMed Web of Science ®Google Scholar
• Bailey MM, Berkland CJ. 2009. Nanoparticle formulations in pulmonary drug delivery. Med Res Rev 29:196–212
   PubMed Web of Science ®Google Scholar
• Bernd H, De Kerviler E, Gaillard S, Bonnemain B. 2009. Safety and tolerability of ultrasmall superparamagnetic iron oxide contrast agent: comprehensive analysis of a clinical development program. Invest Radiol 44:336–42
   PubMed Web of Science ®Google Scholar
• Braakhuis H, Park M, Gosens I, De Jong W, Cassee F. 2014. Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part Fibre Toxicol 11:18
   PubMed Web of Science ®Google Scholar
• Cengelli F, Maysinger D, Tschudi-monnet F, Montet X, Corot C, Petri-Fink A, et al. 2006. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures. J Pharmacol Exp Ther 318:108–16
   PubMed Web of Science ®Google Scholar
• Chellat F, Merhi Y, Moreau A, Yahia L. 2005. Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 26:7260–75
   PubMed Web of Science ®Google Scholar
• Conti G, Tambalo S, Villetti G, Catinella S, Carnini C, Bassani F, et al. 2010. Evaluation of lung inflammation induced by intratracheal administration of LPS in mice: comparison between MRI and histology. Magn Reson Mater Phys Biol Med 23:93–101
   Google Scholar
• Corot C, Robert P, Idee JM, Port M. 2006. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 58:1471–504
   PubMed Web of Science ®Google Scholar
• Elsabahy M, Wooley KL. 2013. Cytokines as biomarkers of nanoparticle immunotoxicity. Chem Soc Rev 42:5552–76
   PubMed Web of Science ®Google Scholar
• Frohlich E. 2012. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed 7:5577–91
   PubMed Web of Science ®Google Scholar
• Geiser M, Kreyling WG. 2010. Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol 7:2
   PubMed Web of Science ®Google Scholar
• Grüttner C, Müller K, Teller J, Westphal F, Foreman A, Ivkov R. 2007. Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy. J Magn Magn Mater 311:181–6
   Web of Science ®Google Scholar
• Hamman JH, Enslin GM, Kotze AF. 2005. Oral delivery of peptide drugs: barriers and developments. BioDrugs 19:165–77
   PubMed Web of Science ®Google Scholar
• Hilger I, Kaiser WA. 2012. Iron oxide-based nanostructures for MRI and magnetic hyperthermia. Nanomedicine (Lond) 7:1443–59
   PubMed Web of Science ®Google Scholar
• Luengo Y, Nardecchia S, Morales MP, Serrano MC. 2013. Different cell responses induced by exposure to maghemite nanoparticles. Nanoscale 5:11428–37
   PubMed Web of Science ®Google Scholar
• Mbeh DA, Franca R, Merhi Y, Zhang XF, Veres T, Sacher E, et al. 2012. In vitro biocompatibility assessment of functionalized magnetite nanoparticles: biological and cytotoxicological effects. J Biomed Mater Res A 100:1637–46
   PubMed Web of Science ®Google Scholar
• Prodan AM, Ciobanu CS, Popa CL, Iconaru SL, Predoi D. 2014. Toxicity evaluation following intratracheal instillation of iron oxide in a silica matrix in rats. BioMed Res Int 2014:Article ID 134260, 13 pages
   Web of Science ®Google Scholar
• Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. 2005. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40:715–24
   PubMed Web of Science ®Google Scholar
• Rosen JE, Chan L, Shieh DB, Gu FX. 2012. Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine 8:275–90
   PubMed Web of Science ®Google Scholar
• Singh N, Jenkins GJ, Asadi R, Doak SH. 2010. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev 1. doi: 10.3402/nano.v1i0.5358
   Google Scholar
• Singh N, Jenkins GJ, Nelson BC, Marquis BJ, Maffeis TG, Brown AP, et al. 2012. The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticles. Biomaterials 33:163–70
   PubMed Web of Science ®Google Scholar
• Sood A, Salih S, Roh D, Lacharme-Lora L, Parry M, Hardiman B, et al. 2011. Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness. Nat Nanotechnol 6:824–33
   PubMed Web of Science ®Google Scholar
• Sung JC, Pulliam BL, Edwards DA. 2007. Nanoparticles for drug delivery to the lungs. Trends Biotechnol 25:563–70
   PubMed Web of Science ®Google Scholar
• Tyler DJ, Robson MD, Henkelman RM, Young IR, Bydder GM, et al. 2007. Magnetic resonance imaging with ultrashort TE (UTE) PULSE sequences: technical considerations. J Magn Reson Imaging 25:279–89
   PubMed Web of Science ®Google Scholar
• van Rijt SH, Bein T, Meiners S. 2014. Medical nanoparticles for next generation drug delivery to the lungs. Eur Respir J 44:765–74
   Google Scholar
• Verma A, Stellacci F. 2010. Effect of surface properties on nanoparticle–cell interactions. Small 6:12–21
   PubMed Web of Science ®Google Scholar
• Villanueva A, Canete M, Roca AG, Calero M, Veintemillas-Verdaguer S, Serna CJ, et al. 2009. The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells. Nanotechnology 20:115103
   PubMed Web of Science ®Google Scholar
• Wahajuddin, Arora S. 2012. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomed 7:3445–71
   PubMed Web of Science ®Google Scholar
• Warheit DB, Donner EM. 2010. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines. Nanotoxicology 4:409–13
   PubMed Web of Science ®Google Scholar
• Xu C, Sun S. 2013. New forms of superparamagnetic nanoparticles for biomedical applications. Adv Drug Deliv Rev 65:732–43
   PubMed Web of Science ®Google Scholar
• Yoo D, Lee JH, Shin TH, Cheon J. 2011. Theranostic magnetic nanoparticles. Acc Chem Res 44:863–74
   PubMed Web of Science ®Google Scholar
• Zhu MT, Feng WY, Wang B, Wang TC, Gu YQ, Wang M, et al. 2008. Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats. Toxicology 247:102–11
   PubMed Web of Science ®Google Scholar
• Zhuang J, Fan K, Gao L, Lu D, Feng J, Yang D, et al. 2012. Ex vivo detection of iron oxide magnetic nanoparticles in mice using their intrinsic peroxidase-mimicking activity. Mol Pharm 9:1983–9
   PubMed Web of Science ®Google Scholar